Sep. 29 at 1:45 PM
$TECH unveils spatial biology advancements — will it spark a stock rally? 🌐
Bio-Techne's RNAscope & COMET innovations could boost clinical workflows, while its 3.9% earnings yield stands strong against an industry at -21.1%. However,
$TECH holds a Zacks Rank #4 (Sell), so tread carefully.
Discover the full story here 👉 https://www.zacks.com/stock/news/2758627/bio-techne-stock-climbs-on-advances-in-spatial-biology-solutions?cid=sm-stocktwits-2-2758627-body-14445&ADID=SYND_STOCKTWITS_TWEET_2_2758627_BODY_14445